227 related articles for article (PubMed ID: 8424417)
1. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
Chang F; Syrjänen S; Kurvinen K; Syrjänen K
Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
[TBL] [Abstract][Full Text] [Related]
2. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
3. [P53 and cancers].
May P; May E
Pathol Biol (Paris); 1995 Mar; 43(3):165-73. PubMed ID: 7675543
[TBL] [Abstract][Full Text] [Related]
4. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
[TBL] [Abstract][Full Text] [Related]
5. Tumourigenesis associated with the p53 tumour suppressor gene.
Chang F; Syrjänen S; Tervahauta A; Syrjänen K
Br J Cancer; 1993 Oct; 68(4):653-61. PubMed ID: 8398688
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor genes.
Levine AJ
Bioessays; 1990 Feb; 12(2):60-6. PubMed ID: 2140509
[TBL] [Abstract][Full Text] [Related]
7. p53 from basic research to clinical applications.
Tominaga O; Hamelin R; Remvikos Y; Salmon RJ; Thomas G
Crit Rev Oncog; 1992; 3(3):257-82. PubMed ID: 1616957
[TBL] [Abstract][Full Text] [Related]
8. [The p53 gene and protein in 2005: new results, promising opportunities].
Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the p53 gene occur in diverse human tumour types.
Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P
Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
[TBL] [Abstract][Full Text] [Related]
11. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
Mendoza-Rodríguez CA; Cerbón MA
Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135).
Yam JW; Zheng JY; Hsiao WL
Biochem Biophys Res Commun; 1999 Dec; 266(2):472-80. PubMed ID: 10600527
[TBL] [Abstract][Full Text] [Related]
13. 3-Methylcholanthrene triggers the differentiation of alveolar tumor cells from canine bronchial basal cells and an altered p53 gene promotes their clonal expansion.
TenHave-Opbroek AA; Shi XB; Gumerlock PH
Carcinogenesis; 2000 Aug; 21(8):1477-84. PubMed ID: 10910947
[TBL] [Abstract][Full Text] [Related]
14. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
[TBL] [Abstract][Full Text] [Related]
15. [Tumor suppressor gene p53--function and significance in gastroenterology].
Schoppmeyer K; Keim V; Mössner J
Z Gastroenterol; 1997 Jun; 35(6):491-509. PubMed ID: 9281241
[TBL] [Abstract][Full Text] [Related]
16. p53: an overview of over two decades of study.
Cheah PL; Looi LM
Malays J Pathol; 2001 Jun; 23(1):9-16. PubMed ID: 16329542
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
[TBL] [Abstract][Full Text] [Related]
18. p53 mutants with changes in conserved region II: three classes with differing antibody reactivity, SV40 T antigen binding and ability to inhibit transformation of rat cells.
Schmieg FI; Simmons DT
Oncogene; 1993 Aug; 8(8):2043-50. PubMed ID: 8393158
[TBL] [Abstract][Full Text] [Related]
19. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.
de Vries A; Flores ER; Miranda B; Hsieh HM; van Oostrom CT; Sage J; Jacks T
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2948-53. PubMed ID: 11867759
[TBL] [Abstract][Full Text] [Related]
20. UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin.
Luo JL; Tong WM; Yoon JH; Hergenhahn M; Koomagi R; Yang Q; Galendo D; Pfeifer GP; Wang ZQ; Hollstein M
Cancer Res; 2001 Nov; 61(22):8158-63. PubMed ID: 11719445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]